Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

<b>Background:</b> The United States Centers for Disease Control and Prevention (CDC) estimates a total obesity rate of 30% for 12 states and a 20% obesity rate nationwide. The obesity epidemic continues to increase in spite of preventative measures undertaken worldwide. Pharmacological...

Full description

Bibliographic Details
Main Authors: Kenneth Blum, Mark S. Gold, Luis Llanos-Gomez, Rehan Jalali, Panayotis K. Thanos, Abdalla Bowirrat, William B. Downs, Debasis Bagchi, Eric R. Braverman, David Baron, Alphonso Kenison Roy, Rajendra D. Badgaiyan
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Environmental Research and Public Health
Subjects:
obesity
nutrigenomics
resting-state functional connectivity
sarcopenia
BMI
percent body fat
Online Access:https://www.mdpi.com/1660-4601/18/18/9774

Internet

https://www.mdpi.com/1660-4601/18/18/9774

Similar Items